An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Anorexia Nervosa
Interventions
DRUG

Donepezil

Study medication will be initiated at 1mg, to be taken before bed. Dosing will follow a flexible titration. The expected titration will be 1 mg for 2 weeks, 2.5 mg for 2 weeks, then 5 mg for 4 weeks. Doses may be lowered from those recommended by the protocol if side effects are significant.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER